Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Diagnosing malignant pleural effusion with the EPISEEK-MPE liquid biopsy

Official title: Development of a Molecular Assay to Diagnose Malignant Pleural Effusions

Run by University of Arizona · NCT07929584 · Data updated 2026-11-12

A test called EPISEEK-MPE is being checked to see if it can tell cancer from non-cancer pleural effusions using fluid already removed for care.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment625 (estimated)
SponsorUniversity of Arizona
Academic / other
Locations2 sites (Tucson, Arizona and 1 other locations)
StatusRecruiting
StartedJanuary 8, 2025
Main results expectedDecember 31, 2026
Study endsMay 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07929584 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with pleural fluid drained for clinical care who consent to use of their fluid for research.

Probably not a fit

Patients with insufficient pleural fluid after drainage or who do not consent to data/sample use may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multi-site validation study evaluates the EPISEEK-MPE liquid biopsy assay as a diagnostic aid for malignant pleural effusions. Researchers compare the test’s results with standard clinical information and patient records to determine reliability across age, race, gender, and ethnicity. The study uses excess pleural fluid from routine drainage and collects medical-record data to assess diagnostic performance and potential survival associations. It aims to establish the EPISEEK-MPE test as a complementary tool to cytology in differentiating malignant from benign effusions.

Why it matters

Potential benefit: If successful, this test could improve accuracy in diagnosing malignant pleural effusions and help guide treatment decisions.

How similar studies have gone: Preliminary work suggests epigenetic liquid biopsy approaches can add diagnostic value in pleural effusions, but this specific multi-site validation is ongoing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients having pleural fluid drained for clinical care (thoracentesis or chest tube placement)
* Consent to have pleural fluid sample used for research

Exclusion Criteria:

\- Insufficient fluid available following clinical drainage procedure

Where it's running

  • Banner University Medical Center South
    Tucson, Arizona, United States
    Recruiting
  • Banner University Medical Center Tucson
    Tucson, Arizona, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.